Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Durham

Showing results (211-220 of 240) with videos related to

Pageof 24
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 20, 1998
Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitisE Minshall, O Ghaffar, L Cameron, et al.
Allergy|November 8, 2014
Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individualsM H Shamji, V Bellido, G W Scadding, et al.
Allergy|November 20, 2012
Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polypsP Gevaert, K T Nouri-Aria, H Wu, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 19, 2011
Immunotherapy for allergic rhinitisS M Walker, S R Durham, S J Till, et al.
Allergy|October 1, 1996
The clinical safety of H1-receptor antagonists. An EAACI position paperG Passalacqua, J Bousquet, C Bachert, et al.
Allergy|March 22, 2000
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical ImmunologyP van Cauwenberge, C Bachert, G Passalacqua, et al.
Allergy|January 12, 2018
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patientsR Mösges, A F Koch, E Raskopf, et al.
Allergy|July 30, 2015
Epitope specificity determines cross-protection of a SIT-induced IgG4 antibodyE Gadermaier, L K James, M H Shamji, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 22, 2018
BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)G K Scadding, H H Kariyawasam, G Scadding, et al.
Pageof 24

Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 20, 1998
Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitisE Minshall, O Ghaffar, L Cameron, et al.
Allergy|November 8, 2014
Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individualsM H Shamji, V Bellido, G W Scadding, et al.
Allergy|November 20, 2012
Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polypsP Gevaert, K T Nouri-Aria, H Wu, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 19, 2011
Immunotherapy for allergic rhinitisS M Walker, S R Durham, S J Till, et al.
Allergy|October 1, 1996
The clinical safety of H1-receptor antagonists. An EAACI position paperG Passalacqua, J Bousquet, C Bachert, et al.
Allergy|March 22, 2000
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical ImmunologyP van Cauwenberge, C Bachert, G Passalacqua, et al.
Allergy|January 12, 2018
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patientsR Mösges, A F Koch, E Raskopf, et al.
Allergy|July 30, 2015
Epitope specificity determines cross-protection of a SIT-induced IgG4 antibodyE Gadermaier, L K James, M H Shamji, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 22, 2018
BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)G K Scadding, H H Kariyawasam, G Scadding, et al.
Pageof 24